Myocardial infarction causes almost 7.3 million deaths each year worldwide. However,
current treatments are more palliative than curative. Presently, cell and protein therapies are …

Despite advancements in modern medicine, the treatment of acute heart failure (AHF) after
acute myocardial infarction (AMI) remains challenging. Milrinone is effective in the treatment …

Background Advances in treatment for acute myocardial infarction (AMI) are likely to have
had a beneficial impact on the incidence of and deaths attributable to heart failure (HF) …

Background There are few data characterizing temporal changes in hospitalization for
recurrent acute myocardial infarction (AMI) after AMI. Methods and Results Using a national …

Objectives To investigate the prevalence, predictors and associations between guideline‐
directed medical therapy (GDMT) and clinical outcomes in acute myocardial infarction (AMI) …

Optimization of medical therapy during discharge planning is vital for improving patient
outcomes after hospitalization for acute myocardial infarction (AMI). However, limited …

Several medications have individually been shown to reduce mortality in patients with acute
coronary syndromes (ACS), but data on long-term outcomes related to the use of …

BACKGROUND: The objectives of this study were to examine the magnitude of, and 20-year
trends in, age differences in short-term outcomes among men and women hospitalized with …

Purpose Trimetazidine (TMZ) improves clinical outcomes in patients with chronic heart
failure and stable coronary artery disease. No study has yet evaluated the efficacy of TMZ in …

β-Blockers in coronary artery disease management - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …